What it's for (Indications)
- Propyphenazone, a pyrazolone derivative, combined with caffeine, is primarily indicated for the symptomatic treatment of mild to moderate pain and febrile conditions.
- This therapeutic combination is commonly employed for various acute painful states, including tension headaches, migraines, dental pain following procedures, muscular pain, and arthralgia.
- It is also effective in alleviating dysmenorrhea and post-traumatic pain.
- The inclusion of caffeine serves to potentiate the analgesic effect of propyphenazone and may help to counteract any mild sedative effects, thereby enhancing patient alertness.
- This formulation is designed for short-term use to provide rapid relief from pain and reduce elevated body temperature in adults and adolescents aged 12 years and older, under medical supervision where appropriate.
- It is not intended for chronic pain management without a thorough diagnostic evaluation.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Specific dosage guidelines are not provided in the available data. Dosage should be determined by a healthcare professional based on individual patient needs and clinical judgment. |
Safety & Warnings
Common Side Effects
- Uncommon side effects include skin rashes, pruritus (itching), erythema, angioedema, breathing problems (e.
- g.
- , dyspnea, asthma), anaphylaxis (serious allergic reactions), and a decrease in the number of blood cells such as thrombocytopenia, leucopenia, agranulocytosis, and pancytopenia.
Serious Warnings
- Black Box Warning: ### Serious Warnings **1. Cardiovascular Thrombotic Events:** Non-steroidal anti-inflammatory drugs (NSAIDs), including propyphenazone, may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use and in patients with pre-existing cardiovascular disease or risk factors for such disease. Patients with known cardiovascular disease may be at greater risk. The use of propyphenazone + caffeine is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. **2. Gastrointestinal Risk:** NSAIDs, including propyphenazone, cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and those with a history of gastrointestinal disease are at greater risk for serious gastrointestinal events. **3. Hematological Reactions (Agranulocytosis):** Propyphenazone, a pyrazolone derivative, carries a serious, potentially life-threatening risk of severe hematological reactions, including agranulocytosis, aplastic anemia, and thrombocytopenia. These reactions can occur acutely and without warning, and their onset may not be dose-dependent or predictable. Patients should be advised to report immediately any signs or symptoms suggestive of bone marrow suppression, such as fever, sore throat, or unusual bleeding/bruising. Regular monitoring of blood counts is strongly advised for patients on prolonged therapy. Immediate discontinuation is mandatory if signs of hematological abnormality are detected. These serious risks necessitate careful consideration of the risk-benefit profile before initiation and during therapy.
- The use of propyphenazone and caffeine combination therapy necessitates careful consideration of potential risks and contraindications.
- Patients with a known history of hypersensitivity or allergic reactions to propyphenazone, other pyrazolones (e.
- g.
- , metamizole, phenazone), or other NSAIDs (including acetylsalicylic acid) should avoid this medication due to the risk of cross-reactivity and severe hypersensitivity reactions, such as bronchospasm, angioedema, or anaphylactic shock.
- This combination is contraindicated in individuals with active gastrointestinal ulcers, bleeding, or perforation, or a history thereof, due to the NSAID component's potential to exacerbate these conditions.
- Severe hepatic impairment, severe renal insufficiency, or severe uncontrolled heart failure also represent absolute contraindications.
- Hematological disorders, particularly a history of agranulocytosis or aplastic anemia, warrant extreme caution or contraindication, as pyrazolones are associated with these rare but serious adverse events.
- Pregnant women, especially during the third trimester, and breastfeeding mothers should generally avoid this medication unless absolutely necessary and under strict medical supervision, due to potential fetal harm and excretion into breast milk.
- Caution is advised in patients with hypertension, cardiac arrhythmias, glaucoma, hyperthyroidism, anxiety disorders, or sleep disturbances due to the caffeine component.
- Concomitant use with other NSAIDs, anticoagulants, methotrexate, or lithium requires close monitoring due to potential drug interactions.
- Patients should be advised against prolonged self-medication and to seek medical advice if symptoms persist or worsen.
How it Works (Mechanism of Action)
The pharmacological efficacy of this combination therapy stems from the distinct but synergistic actions of its two active components. Propyphenazone, a non-steroidal anti-inflammatory drug (NSAID) of the pyrazolone class, exerts its primary analgesic and antipyretic effects by inhibiting the cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2. This inhibition leads to a significant reduction in the synthesis of prostaglandins, which are key mediators of pain, inflammation, and fever at peripheral and central sites. By diminishing prostaglandin levels, propyphenazone effectively reduces nociceptive input and resets the hypothalamic thermoregulatory center. Caffeine, a central nervous system (CNS) stimulant, complements propyphenazone's action through multiple pathways. Its primary mechanism involves competitive antagonism of adenosine receptors (A1 and A2A) in the brain, leading to increased neuronal activity, enhanced alertness, and potential augmentation of endogenous pain inhibitory pathways. Furthermore, caffeine can enhance the absorption of propyphenazone from the gastrointestinal tract and is believed to directly potentiate the analgesic effect of NSAIDs, allowing for a more rapid onset and possibly a greater magnitude of pain relief.